comparemela.com

Latest Breaking News On - Brian cheng - Page 3 : comparemela.com

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

JPMorgan says buy this immunology stock primed to rally nearly 40%

The biotech firm could emerge as a key player treating autoimmune diseases, JPMorgan said.

Roivant Sciences Ltd (NASDAQ:ROIV) Q3 2023 Earnings Call Transcript

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.